Growth Hormone Releasing Hormone Receptor in Human Breast Cancer Cell Line MCF-7

  • Grégoire Prévost
  • Nathalie Veber
  • Lucien Israël
  • Philippe Planchon
Part of the Serono Symposia USA Norwell, Massachusetts book series (SERONOSYMP)

Abstract

Growth hormone secretion from the pituitary is regulated by somatostatin (SS) and growth hormone releasing hormone (GHRH) (1,2). Interestingly, SS actions via specific receptor subtypes are widely described in peripheral normal and tumoral tissues (3, 4). In contrast, the synthesis of GHRH and its actions in peripheral tissues are poorly reported (5–7). In addition, the recently cloned GHRH receptors having seven membrane-spanning domains were only expressed in the pituitary, thus reinforcing an exclusive pituitary activity (8, 9). However, the handling of GHRH is technically challenging due to the very “sticky” GHRH and could lead to doubtful data, particularly when the receptor level is low.

Keywords

Adenoma Adenosine Prostaglandin PGE2 Neuroblastoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg W. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982;218:585–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Brazeau P, Vale W, Burgas R, Ling N, Butscher M, Rivier J, Guillemin R. Hypothalamic polypeptides that inhibit the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Prevost G, Lanson M, Thomas F, Veber N, Gonzalez W, Beaupain R, Starzec A, Bogden AE. Molecular heterogeneity of somatostatin analog BIM23014C receptors in human breast carcinoma cells using the chemical cross-linking assay. Cancer Res 1992;52:843–50.PubMedGoogle Scholar
  4. 4.
    Lamberts SWJ, Krenning E, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatments of tumors. Endocr Rev 1991;12:450–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Weigent DA, Blalock JE. The production and function of growth hormone in the immune system. In: Growth hormone II: basic and clinical aspects, Serono Symposia USA, Norwell, MA, 1994 (abstr.): 1992:10.Google Scholar
  6. 6.
    Srivastava CH, Breyer PR, Rothorock JK, Peredo MJ, Pescovitz OH. A new target for growth hormone releasing hormone action in rat: the Sertoli cell. Endocrinology 1993;133:1478–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Moretti C, Bagnato A, Solan N, Frajesse G, Catt KJ. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation. Endocrinology 1990;127:2117–226.PubMedCrossRefGoogle Scholar
  8. 8.
    Mayo KE. Molecular cloning and expression of a pituitary-specific receptor for growth hormone. Mol Endocrinol 1992;6:1734–44.PubMedCrossRefGoogle Scholar
  9. 9.
    Gaylinn BD, Harisson JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone releasing hormone. Mol Endocrinol 1993;7:77–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Prevost G, Provost P, Salle V, Lanson M, Thomas F. A cross-linking assay allows the detection of receptors for the somatostatin analogue Lanreotide in human breast tumours. Eur J Cancer 1993;29:1589–92.CrossRefGoogle Scholar
  11. 11.
    Patel KV, Schrey MP. Activation of inositol phospholipid signaling and Ca efflux in human breast cancer cells by bombesin. Cancer Res 1990;50:235–9.PubMedGoogle Scholar
  12. 12.
    Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM. Growth of human breast breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 1985;313:231–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Prevost G, Foehrle E, Thomas F, Pihan I, Veber N, Starzec A, Israel L. Growth of human breast cancer cells inhibited by the somatostatin analog BIM23014C (Somatuline). Endocrinology 1991;128:323–9.CrossRefGoogle Scholar
  14. 14.
    Gaylinn B, Lyons C, Zysk J, Clarke I. Thorner, M. Photoaffinity cross-linking to the pituitary receptor for growth hormone releasing factor. Endocrinology 1994;135:950–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Thorner MO, Spiess J, Vance ML, Rogol AD, Kaiser DL, Webster JD, Rivier J, Borges JL, Bloom SR, Cronin MJ, Evans WS, Macleod RM, Vale W. Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1983;1:24–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Bowers CC, Sartor AO, Reynolds GA, Bagder TM. On the actions of the growth hormone releasing hexapeptide GHRP. Endocrinology 1991;128:2027–35.PubMedCrossRefGoogle Scholar
  17. 17.
    Prevost G, Bourgeois Y, Mormont C, Lerrant Y, Veber N, Poupon MF, Thomas F. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma. Life Sci 1994;55:155–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Ciocca DR, Puy LA, Fasoli LC, Tello O, Aznar JC, Gargo FE, Papa IS, Sonego R. Corticotropin releasing hormone, luteinizing hormone releasing hormone, growth hormone releasing hormone and somatostatin like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res Treat 1990;15:175–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Gonzalez-Crespo S, Boronat A. Expression of the rat growth hormone releasing hormone gene in placenta is directed by an alternative promoter. Proc Natl Acad Sci USA 1991;88:8749–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Grégoire Prévost
  • Nathalie Veber
  • Lucien Israël
  • Philippe Planchon

There are no affiliations available

Personalised recommendations